Related Experiment Video
Updated: Jul 17, 2026

10:32
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
Protect from light: photodegradation and protein biologics
Bruce A Kerwin1, Richard L Remmele
1Department of Protein Pharmaceutics, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, USA. bkerwin@amgen.com
Journal of Pharmaceutical Sciences
|January 19, 2007
Summary
Protein photodegradation, a known issue, requires more study in biopharmaceuticals. Understanding light-induced damage is key to ensuring the safety and effectiveness of these vital medical products.
Area of Science:
- Biochemistry
- Pharmaceutical Science
Background:
- Protein exposure to light causes chemical and physical degradation.
- Primary photooxidation affects amino acid residues like tryptophan and tyrosine.
- Photodegradation is a significant factor in protein breakdown, but understudied in biopharmaceuticals.
Purpose of the Study:
- To review major protein photodegradation pathways.
- To describe existing data on biopharmaceutical photodegradation.
- To highlight methods for mitigating photodegradation and encourage further research.
Main Methods:
- Literature review of protein photodegradation.
- Analysis of limited data on biopharmaceutical photodegradation.
- Summary of protective strategies.
Main Results:
- Identified key amino acids susceptible to photooxidation.
- Highlighted the scarcity of research on biopharmaceutical photodegradation.
- Outlined potential impacts on protein structure, stability, bioactivity, and immunogenicity.
Conclusions:
- Photodegradation poses risks to biopharmaceutical products.
- Further research is needed to understand and prevent light-induced damage.
- Addressing photodegradation will enhance biopharmaceutical safety and efficacy.

